Fri, Dec 19, 2014, 10:13 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Clovis Oncology, Inc. Message Board

smithjjj5 2 posts  |  Last Activity: Oct 30, 2014 8:01 AM Member since: Sep 18, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • smithjjj5 by smithjjj5 Oct 30, 2014 8:01 AM Flag

    NeoGenomics Reports 38% increase in Revenue to a Record $23.2 Million and Adjusted EBITDA of $2.6 Million for the Third Quarter of 2014

    Third Quarter 2014 Highlights:

    38% increase in consolidated revenue
    23% growth in base NeoGenomics revenue
    33% growth in base NeoGenomics test volume
    Consolidated Adjusted EBITDA increase of 21.9%
    EPS of ($.01) per share - $.01 per share excluding one-time costs
    Completion of PathLogic acquisition
    Successful equity financing and strong cash collections

  • Reply to

    USU to LEU conversion rate

    by sponge_bob_is_no_square Sep 30, 2014 7:35 AM
    smithjjj5 smithjjj5 Sep 30, 2014 8:25 AM Flag

    The exchange ratio is approximately 0.0917, which means 1000 shares of USU will be exchanged for approximately 92 shares of LEU.

CLVS
56.64-1.04(-1.80%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.